IκB-β Polyclonal Antibody

Alias:NFKBIB;IKBB;TRIP9;NF-kappa-B inhibitor beta;NF-kappa-BIB;I-kappa-B-beta;IkB-B;IkB-beta;IkappaBbeta;Thyroid receptor-interacting protein 9;TR-interacting protein 9;TRIP-9

CatalogNo:HJRLT2421

Specifications

50μL;100μL

Delivery date

Spot

Target

IκB β

Reactivity

Human,Mouse

Application - After Update

WB,IHC

MW(Observed)

37kD

Host Species

Rabbit

Isotype

IgG

Modify

Unmodified

Recommended dilution ratio

WB 1:500-2000;IHC 1:50-300

compose

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Store

-15°C to -25°C/1 year(Do not lower than -25°C)

Soncentration

1 mg/ml

Clonality

Polyclonal

Immunogen

The antiserum was produced against synthesized peptide derived from human IkappaB-beta. AA range:4-53

Specificity

IκB-β Polyclonal Antibody detects endogenous levels of IκB-β protein.

Gene name

NFKBIB

Protein name

NF-kappa-B inhibitor beta

Organism-1

Human